In vitro prostanoid release from spinal cord following peripheral inflammation: Effects of substance P, NMDA and capsaicin

British Journal of Pharmacology

Volumn 126, Issue 6, 1999, Pages 1333-1340

  Dirig, David M ^a   Yaksh, Tony L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

Author keywords

Capsaicin; Kaolin carrageenan; Knee joint inflammation; NMDA; Prostaglandin; Prostanoid; Spinal; Substance P

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; CAPSAICIN; CARRAGEENAN; IBUPROFEN; KAOLIN; N METHYL DEXTRO ASPARTIC ACID; NEUROKININ 1 RECEPTOR; PROSTAGLANDIN E2; PROSTANOID; SUBSTANCE P; THROMBOXANE B2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HYPERALGESIA; INFLAMMATION; KNEE; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RAT; SPINAL CORD;

EID: 0033037253     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702427     Document Type: Article

References (68)

1. ABBADIE, C., BROWN, J.L., MANTYH, P.W. & BASBAUM, A.I. (1996). Spinal cord substance P receptor immunoreactivity increases in both inflammatory and nerve injury models of persistent pain. Neuroscience, 70, 201-209.
2. BEICHE, F., KLEIN, T., NUSING, R., NEUHUBER, W. & GOPPELT-STRUEBE, M. (1998). Localization of cyclooxygenase-2 and prostaglandin E2 receptor EP3 in the rat lumbar spinal cord. J. Neuroimmunol., 89, 26-34.
3. BEICHE, F., SCHEUERER, S., BRUNE, K., GEISSLINGER, G. & GOPPELT-STRUEBE, M. (1996). Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett., 390, 165-169.
4. BROWN, J.L., LIU, H., MAGGIO, LE., VIGNA, S.R., MANTYH, P.W. & BASBAUM, A.I. (1995). Morphological characterization of substance P receptor-immunoreactive neurons in the rat spinal cord and trigeminal nucleus caudalis. J. Comp. Neurol., 356, 327-344.
5. COLEMAN, R.A., SMITH, W.L. & NARUMIYA, S. (1994). International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev., 46, 205-229.
6. DE BIASI, S. & RUSTIONI, A. (1988). Glutamate and substance coexist in primary afferent terminals in the superficial laminae of spinal cord. Proc. Natl. Acad. Sci. U.S.A., 85, 7820-7824.
7. DIRIG, D.M., CONWAY, C.M., ISAKSON, P.C. & YAKSH, T.L. (1998a). Spinal cyclooxygenase-2 (COX-2) inhibition blocks intrathecal Substance P-evoked thermal hyperalgesia in rats. Soc. for Neurosci. (Abstract), 155.12.
8. DIRIG, D.M., DUFFIN, K., ROSSI, S., ISAKSON, P. & YAKSH, T.L. (1996). Evoked release of eicosanoids from rat spinal cord in vitro with correlative quantitation by radioimmunoassay (RIA) and negative-ion electrospray mass spectrometry (ESI-MS). 8th World Congress on Pain (Abstract), 135.
9. DIRIG, D.M., HUA, X.Y. & YAKSH, T.L. (1997). Temperature dependency of basal and evoked release of amino acids and calcium gene-related peptide from rat dorsal spinal cord. J. Neurosci., 17, 4406-4414.
10. DIRIG, D.M., ISAKSON, P.C. & YAKSH, T.L. (1998b). Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats. J. Pharmacol. Exp. Ther., 285, 1031-1038.
11. DIRIG, D.M. & YAKSH, T.L. (1996). Thermal hyperalgesia in rat evoked by intrathecal substance P at multiple stimulus intensities reflects an increase in the gain of nociceptive processing. Neurosci. Lett., 220, 93-96.
12. DOUGHERTY, P.M. & WILLIS, W.D. (1991). Enhancement of spinothalamic neuron responses to chemical and mechanical stimuli following combined micro-iontophoretic application of N-methyl-D-aspartic acid and substance P. Pain, 47, 85-93.
13. DUGGAN, A.W., HENDRY, I.A., MORTON, C.R., HUTCHISON, W.D. & ZHAO, Z.Q. (1988). Cutaneous stimuli releasing immunoreactive substance P in the dorsal horn of the cat. Brain Res., 451, 261-273.
14. DUGGAN, A.W., & JOHNSTON, G.A. (1970). Glutamate and related amino acids in cat spinal roots, dorsal root ganglia and peripheral nerves, J. Neurochem., 17, 1205- 1208.
15. FERREIRA, S.H., MONCADA, S. & VANE, J.R. (1971). Indomethacin and aspirin abolish prostaglandin release from the spleen. Nature New Biol., 231, 237-239.
16. GARRY, M.G. & HARGREAVES, K.M. (1992). Enhanced release of immunoreactive CGRP and substance P from spinal dorsal horn slices occurs during carrageenan inflammation. Brain Res., 582, 139-142.
17. GO, V.L. & YAKSH, T.L. (1987). Release of substance P from the cat spinal cord. J. Physiol., 391, 141-167.
18. GOLD, M.S., DASTMALCHI, S. & LEVINE, J.D. (1996a). Coexpression of nociceptor properties in dorsal root ganglion neurons from the adult rat in vitro. Neuroscience, 71, 265-275.
19. GOLD, M.S., REICHLING, D.B., SHUSTER, M.J. & LEVINE, J.D. (1996b). Hyperalgesic agents increase a tetrodotoxin-resistant Na + current in nociceptors. Proc. Natl. Acad. Sci. U.S.A., 93, 1108-1112.
20. GOPPELT-STRUEBE, M. & BEICHE, F. (1997). Cyclooxygenase-2 in the spinal cord: localization and regulation after a peripheral inflammatory stimulus. Adv. Exp. Med. Biol., 433, 213-216.
21. GRANSTROM, E. & KINDAHL, H. (1978). Radioimmunoassay of prostaglandins and thromboxanes. Adv. Prostaglandin Thromboxane Res., 5, 119-210.
22. HANDWERKER, H.O., KILO, S. & REEH, P.W. (1991). Unresponsive afferent nerve fibres in the sural nerve of the rat. J. Physiol., 435, 229-242.
23. HENRY, J.L. (1993). Participation of substance P in spinal physiological responses to peripheral aversive stimulation. Regul. Pept., 46, 138-143.
24. HINGTGEN, C.M. & VASKO. M.R. (1994). Prostacyclin enhances the evoked-release of substance P and calcitonin gene-related peptide from rat sensory neurons. Brain Res., 655, 51-60.
25. HOPE, P.J., JARROTT, B., SCHAIBLE, H.G., CLARKE, R.W. & DUGGAN, A.W. (1990). Release and spread of immunoreactive neurokinin A in the cat spinal cord in a model of acute arthritis. Brain Res., 533, 292-299.
26. HUA, X.-Y., CHEN, P., MARSALA, M. & YAKSH, T.L. (1998). Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids. Neuroscience, 89, 525-534.
27. JOBKE, A, PESKAR, B.A. & PESKAR, B.M. (1973). On the specificity of antisera against prostaglandins A2 and E2. FEBS Lett., 37, 192-196.
28. KOCHER, L., ANTON, F., REEH, P.W. & HANDWERKER, H.O. (1987). The effect of carrageenan-induced inflammation on the sensitivity of unmyelinated skin nociceptors in the rat. Pain, 29, 363.
29. MALMBERG, A.B., RAFFERTY, M.F. & YAKSH, T.L. (1994). Antinociceptive effect of spinally delivered prostaglandin E receptor antagonists in the formalin test on the rat. Neurosci. Lett., 173, 193-196.
30. MALMBERG, A.B. & YAKSH, T.L. (1992a). Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J. Pharmacol. Exp. Ther., 263, 136-146.
31. MALMBERG, A.B. & YAKSH, T.L. (1992b). Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science, 257, 1276-1279.
32. MALMBERG, A.B. & YAKSH, T.L. (1994). Capsaicin-evoked prostaglandin E2 release in spinal cord slices: relative effect of cyclooxygenase inhibitors. Eur. J. Pharmacol., 271, 293-299.
33. MALMBERG, A.B. & YAKSH, T.L. (1995). Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats. J. Neurosci., 15, 2768-2776.
34. MANTYH, P.W., DEMASTER, E., MLHOTRA, A., GHILARDI, J.R., ROGERS, S.D., MANTYH, C.R., LIU, H., BASBAUM, A.I., VIGNA, S.R., MAGGIO, J.E. & SIMONE, D.A. (1995). Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science, 268, 1629-1632.
35. MARRIOTT, D.R. & WILKIN, G.P. (1993). Substance P receptors on O-2A progenitor cells and type-2 astrocytes in vitro. J. Neurochem., 61, 826-834.
36. MARRIOTT, D., WILKIN, G.P., COOTE, P.R. & WOOD, J.N. (1991a). Eicosanoid synthesis by spinal cord astrocytes is evoked by substance P; possible implications for nociception and pain. Adv. Prostaglandin Thromboxane Leukot. Res., 21B, 739-741
37. MARRIOTT, D.R., WILKIN, G.P. & WOOD, J.N. (1991 b). Substance P-induced release of prostaglandins from astrocytes: regional specialisation and correlation with phosphoinositol metabolism. J. Neurochem., 56, 259-265.
38. MARSALA, M., MALMBERG, A.B. & YAKSH, T.L. (1995). A chronic spinal dialysis catheter for use in the unanesthetized rat: Methodology and application. J. Neurosci. Meth., 62, 43-53.
39. MATSUMURA, K., WATANABE, Y., IMAI-MATSUMURA, K., CONOLLY, M., KOYAMA, Y., ONOE, H. & WaTANABE, Y. (1992). Mapping of prostaglandin E2 binding sites in rat brain using quantitative autoradiography. Brain Res., 581, 292 -298.
40. MILLER, R.J. (1987). Multiple calcium channels and neuronal function. Science, 235, 46-52.
41. MONCADA, S., FERREIRA, S.H. & VANE, J.R. (1973). Prostaglandins, aspirin-like drugs and the oedema of inflammation. Nature, 246, 217-219.
42. MURATA, T., USHIKUBI, F., MATSUOKA, T., HIRATA, M., YAMAAKI, A., SUGIMOTO, Y., ICHIKAWA, A., AZE, Y., TANAKA, T., YOSHIDA, N., UENO, A., OH-ISHI, S. & NARUMIYA, S. (1997). Altered pain perception and inflammatory responses in mice lacking prostacyclin receptor. Nature, 388, 678-682.
43. NAGASAKA, H., AWAD, H. & YAKSH, T.L. (1996). Peripheral and spinal actions of opioids in the blockade of the autonomic response evoked by compression of the inflamed knee joint. Anesthesiology, 85, 808-816.
44. NEUGEBAUER, V., GEISSLINGER, G., RUMENAPP, P., WEIRETTER, F., SZELENYI, I., BRUNE, K. & SCHAIBLE, H.G. (1995). Antinociceptive effects of R(-)- and S(+)-flurbiprofen on rat spinal dorsal horn neurones rendered hyperexcitable by an acute knee joint inflammation. J. Pharmacol. Exp. Ther., 275, 618-28.
45. OHUCHI, K., SATO, H. & TSURUFUJI, S. (1976). The content of prostaglandin E and prostaglandin F2alpha in the exudate of carrageenin granuloma of rats. Biochim. Biophys. Acta, 424, 439-448.
46. OIDA, H., NAMBA, T., SUGIMOTO, Y., USHIKUBI, F., OHISHI, H., ICHIKAWA, A. & NARUMIYA, S. (1995). In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs. Br. J. Pharmacol., 116, 2828-2837.
47. PALMA, C., MINGHETTI, L., ASTOLFI, M., AMBROSINI, E., SILBERTEIN, F.C., MANZINI, S., LEVI, G. & ALOISI, F. (1997). Functional characterization of substance P receptors on cultured human spinal cord astrocytes: synergism of substance P with cytokines in inducing interleukin-6 and prostaglandin E2 production. Glia, 21, 183-193.
48. PORTANOVA, J.P., ZHANG, Y., ANDERSON, G.D., HAUSER, S.D., MASFERRER, J.L., SEIBERT, K., GREGORY, S.A. & ISAKSON, P.C. (1996). Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J. Exp. Med., 184, 883-891.
49. PUIG, S. & SORKIN, L.S. (1996). Formalin-evoked activity in identified primary afferent fibers: Systematic lidocaine suppresses phase 2 activity. Pain, 64, 345-355.
50. RAJA, S.N., MEYER, R.A. & CAMPBELL, J.N. (1988). Peripheral mechanisms of somatic pain. Anesthesiology, 168, 571-590.
51. SCHAFER, M.K., NOHR, D., KRAUSE, J.E. & WEIHE, E. (1993). Inflammation-induced upregulation of NK 1 receptor mRNA in dorsal horn neurones. Neuroreport, 4, 1007-1010.
52. SLUKA, K.A. & WESTLUND, K.N. (1993a). Behavioral and immunohistochemical changes in an experimental arthritis model in rats. Pain, 55, 367-377.
53. SLUKA, K.A. & WESTLUND, K.N. (1993b). Centrally administered non-NMDA but not NMDA receptor antagonists block peripheral knee joint inflammation. Pain, 55, 217-225.
54. SMITH, J.B. & WILLIS, A.L. (1971). Aspirin selectively inhibits prostaglandin production in human platelets. Nature New Biol., 231, 235-237.
55. SMITH, S.J. & AUGUSTINE, G.J. (1988). Calcium ions, active zones and synaptic transmitter release. Trends Neurosci., 11, 458-464.
56. SMITH, W.L. & DEWITT, D.L. (1996). Prostaglandin endoperoxide H synthases-1 and -2. Adv. Immunol., 62, 167-215.
57. SOUSA, B.N. & HORROCKS, L.A. (1979). Development of rat spinal cord: I. Weight and length with a method for rapid removal. Dev. Neurosci., 2, 115-121.
58. UDA, R., HORIGUCHI, S., ITO, S., HYODO, M. & HAYAISHI, O. (1990). Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2 alpha to conscious mice. Brain Res., 510, 26-32.
59. VANE, J.R. (1971). Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol., 231, 232-235.
60. VASKO, M.R. (1995). Prostaglandin-induced neuropeptide release from spinal cord. Prog. Brain Res., 104, 367-380.
61. VASKO, M.R., ZIRKELBACH, S.L. & WAITE, K.J. (1993). Prostaglanins stimulate the release of substance P from rat spinal cord slices. In Progress in Pharmacology and Clinical Pharmacology. eds. Jurna, I. & Yaksh, T.L. pp. 69-89. Stuttgart, New York: Gustav Fischers Verlag.
62. WILLINGALE, H.L., GARDINER, N.J., MCLYMONT, N., GIBLETT, S. & GRUBB, B.D. (1997). Prostanoids synthesized by cyclooxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability. Br. J. Pharmacol., 122, 1593-1604.
63. WOOLF, C.J. (1983). Evidence for a central component of post-injury pain hypersensitivity. Nature, 306, 686-688.
64. YAKSH, T.L. (1982). Central and peripheral mechanism for the antialgesic action of acetylsalicylic acid. In Aectylsalicylic Acid: New Uses for an Old Drug. eds. Barnet, J.M., Hirsh, J. & Mustard, J.F. pp. 137-152, New York: Raven Press.
65. YAKSH, T.L., DIRIG, D.M. & MALMBERG, A.B. (1998). Mechanism of action of nonsteroidal anti-inflammatory drugs. Canc. Invest., 16, 509-527.
66. YAKSH, T.L., JESSELL, T.M., GAMSE, R., MUDGE, A.W. & LEEMAN, S.E. (1980). Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo. Nature, 286, 155-157.
67. YANG, L., MARSALA, M. & YAKSH, T.L. (1996). Characterization of time course of spinal amino acids, citrulline, and PGE2 release after carrageenan/kaolin-induced knee joint inflammation: a chronic microdialysis study. Pain, 67, 345-354.
68. YASPHAL, K., WRIGHT, D.M. & HENRY, J.L. (1982). Substance P reduces tail-flick latency: implications for chronic pain syndromes. Pain, 14, 155-167.